Impact of antibiotics on residual cancer burden and pathologic response rates during neoadjuvant pembrolizumab in breast cancer (BC).

e12622Background: Antibiotic exposure during immunotherapy has been shown to negatively affect clinical outcomes in metastatic melanoma and non-small cell lung cancer. We tested whether antibiotics...